These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 28353057)

  • 1. Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy.
    Tan J; Paquette V; Levine M; Ensom MHH
    Clin Pharmacokinet; 2017 Nov; 56(11):1267-1285. PubMed ID: 28353057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
    Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
    Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M; Albani F; Riva R; Baruzzi A
    Ther Drug Monit; 2004 Aug; 26(4):375-9. PubMed ID: 15257066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam use in pregnancy.
    Longo B; Forinash AB; Murphy JA
    Ann Pharmacother; 2009 Oct; 43(10):1692-5. PubMed ID: 19690219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam: treatment in epilepsy.
    Ben-Menachem E
    Expert Opin Pharmacother; 2003 Nov; 4(11):2079-88. PubMed ID: 14596661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
    Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
    Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam: a different approach to the pharmacotherapy of epilepsy.
    Welty TE; Gidal BE; Ficker DM; Privitera MD
    Ann Pharmacother; 2002 Feb; 36(2):296-304. PubMed ID: 11847952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of levetiracetam as an anti-epileptic drug.
    Jain KK
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1611-24. PubMed ID: 11060765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetic characteristics of levetiracetam.
    Patsalos PN
    Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):123-9. PubMed ID: 12731458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary efficacy of levetiracetam in children.
    Glauser TA; Dulac O
    Epileptic Disord; 2003 May; 5 Suppl 1():S45-50. PubMed ID: 12915341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics and indications of levetiracetam].
    Herranz JL; Argumosa A
    Rev Neurol; 2002 Sep; 35 Suppl 1():S110-6. PubMed ID: 12373663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam: a novel antiepileptic drug.
    Hovinga CA
    Pharmacotherapy; 2001 Nov; 21(11):1375-88. PubMed ID: 11714211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
    Lancelin F; Franchon E; Kraoul L; Garciau I; Brovedani S; Tabaouti K; Landré E; Chassoux F; Paubel P; Piketty ML
    Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C; De Smedt H; Stockis A
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
    Patsalos PN
    Pharmacol Ther; 2000 Feb; 85(2):77-85. PubMed ID: 10722121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Drug Monitoring of Levetiracetam in Different Trimesters of Pregnant Women with Epilepsy in a Tertiary Care Center: A Prospective Study.
    Kumaravel J; Sarma P; Suri V; Singh P; Prakash A; Medhi B
    Neurol India; 2024 Mar; 72(2):358-363. PubMed ID: 38691482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
    Glauser TA; Mitchell WG; Weinstock A; Bebin M; Chen D; Coupez R; Stockis A; Lu ZS
    Epilepsia; 2007 Jun; 48(6):1117-22. PubMed ID: 17442002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levetiracetam].
    Salas-Puig J; Calleja S
    Neurologia; 2001 Nov; 16(9):427-32. PubMed ID: 11742623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newer therapies in the drug treatment of epilepsy.
    McAuley JW; Biederman TS; Smith JC; Moore JL
    Ann Pharmacother; 2002 Jan; 36(1):119-29. PubMed ID: 11816240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.